Our Baltimore-based clinical research center has a team of experienced PIs, medical and supporting staff that have successfully conducted over 200 Phase l and Phase ll clinical trials.  The center specializes in integrated FIH, TQT/EPQT, human abuse potential and Japanese and Chinese ethnobridging, with a therapeutic focus on infectious disease, CNS, dermatology, metabolism and respiratory diseases, to conduct clinical trial Phases I and II in support of clinical development.